Naratuximab emtansine Antibody
Naratuximab emtansine (IMGN529) is a CD37-targeting antibody-drug conjugate (ADC) that delivers the cytotoxic agent DM1 into cells, causing microtubule disruption, cell cycle arrest, and apoptosis. It has been investigated in preclinical and clinical research for hematological malignancies, including non-Hodgkin lymphoma.
Product Specifications
Target
Apoptosis, Antibody-Drug Conjugates (ADCs)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog